UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tumor‐Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel‐Enhanced Immunotherapy with Polarization toward M1‐Type Macrophages on Triple Negative Breast Cancers

Advanced materials (Weinheim), 2019-12, Vol.31 (52), p.e1904997-n/a

2019

Volltextzugriff (PDF)

PEG‐PLA nanoparticles decorated with small‐molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells

Journal of cellular physiology, 2020-05, Vol.235 (5), p.4618-4630

2020

Volltextzugriff (PDF)

Bile Acid Tethered Docetaxel‐Based Nanomicelles Mitigate Tumor Progression through Epigenetic Changes

Angewandte Chemie International Edition, 2021-03, Vol.60 (10), p.5394-5399

International ed. in English, 2021

Volltextzugriff (PDF)

A novel encapsulation approach to enhance the delivery and antitumor activity of docetaxel in breast cancer therapy

Journal of pharmaceutical sciences, 2024-11, Vol.113 (11), p.3362-3374

2024

Volltextzugriff (PDF)

Novel co‐delivery of oridonin and docetaxel nanoliposome for an enhanced antitumor effect on esophageal cancer

The journal of gene medicine, 2024-08, Vol.26 (8), p.e3725-n/a

2024

Volltextzugriff (PDF)

An improved LC–MS/MS method for determination of docetaxel and its application to population pharmacokinetic study in Chinese cancer patients

Biomedical chromatography, 2020-08, Vol.34 (8), p.e4857-n/a

2020

Volltextzugriff (PDF)

Phase II clinical trial of docetaxel and trastuzumab for HER2-positive advanced extramammary Paget's disease (EMPD-HER2DOC)

The oncologist (Dayton, Ohio), 2024-09, Vol.29 (9), p.e1201-e1208

2024

Volltextzugriff (PDF)

Role of chemotherapy in prostate cancer

Asian journal of andrology, 2018-05, Vol.20 (3), p.221-229

2018

Volltextzugriff (PDF)

A vitamin D‐based strategy overcomes chemoresistance in prostate cancer

British journal of pharmacology, 2024-11, Vol.181 (21), p.4279-4293

2024

Volltextzugriff (PDF)

A Population Pharmacokinetic Model of Oral Docetaxel Coadministered With Ritonavir to Support Early Clinical Development

Journal of clinical pharmacology, 2020-03, Vol.60 (3), p.340-350

2020

Volltextzugriff (PDF)

NOTCH3 promotes docetaxel resistance of prostate cancer cells through regulating TUBB3 and MAPK signaling pathway

Cancer science, 2024-02, Vol.115 (2), p.412-426

2024

Volltextzugriff (PDF)

Secondary analysis of late major gastrointestinal and genitourinary toxicities in unfavorable‐risk prostate cancer patients receiving docetaxel: Insights from a randomized trial

Cancer, 2024-07, Vol.130 (13), p.2287-2293

2024

Volltextzugriff (PDF)

Prospective Observational Study of Ramucirumab Plus Docetaxel After Combined Chemoimmunotherapy in Patients With Non-Small-Cell Lung Cancer

The oncologist (Dayton, Ohio), 2024-05, Vol.29 (5), p.e681-e689

2024

Volltextzugriff (PDF)

Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer

Cochrane database of systematic reviews, 2019-02, Vol.2 (2), p.CD012873

2019

Volltextzugriff (PDF)

Radiation recall reaction induced by gemcitabine/docetaxel in children: A retrospective study on risk factors and outcomes

Pediatric blood & cancer, 2024-10, Vol.71 (10), p.e31221-n/a

2024

Volltextzugriff (PDF)

Systemic therapies for metastatic hormone‐sensitive prostate cancer: network meta‐analysis

BJU international, 2022-04, Vol.129 (4), p.423-433

2022

Volltextzugriff (PDF)

Vitamin E D‐alpha‐tocopheryl polyethylene glycol 1000 succinate‐conjugated liposomal docetaxel reverses multidrug resistance in breast cancer cells

Journal of pharmacy and pharmacology, 2019-08, Vol.71 (8), p.1243-1254

2019

Volltextzugriff (PDF)

Docetaxel/cabazitaxel and fatty acid binding protein 5 inhibitors produce synergistic inhibition of prostate cancer growth

The Prostate, 2020-01, Vol.80 (1), p.88-98

2020

Volltextzugriff (PDF)

Neoadjuvant docetaxel plus carboplatin vs epirubicin plus cyclophosphamide followed by docetaxel in triple‐negative, early‐stage breast cancer (NeoCART): Results from a multicenter, randomized controlled, open‐label phase II trial

International journal of cancer, 2022-02, Vol.150 (4), p.654-662

2022

Volltextzugriff (PDF)

Reversed‐phase high‐performance liquid chromatography: A fast and efficient analytical method to quantify docetaxel‐loaded pegylated liposomes in release study

Journal of separation science, 2021-11, Vol.44 (21), p.3986-3995

2021

Volltextzugriff (PDF)

Docetaxel reintroduction in patients with metastatic castration‐resistant docetaxel‐sensitive prostate cancer: a retrospective multicentre study

BJU international, 2010-10, Vol.106 (7), p.974-978

2010

Volltextzugriff (PDF)

Patient‐reported and clinician‐reported chemotherapy‐induced peripheral neuropathy in patients with early breast cancer: Current clinical practice

Cancer, 2019-09, Vol.125 (17), p.2945-2954

2019

Volltextzugriff (PDF)

Role of 1‐Deoxysphingolipids in docetaxel neurotoxicity

Journal of neurochemistry, 2020-09, Vol.154 (6), p.662-672

2020

Volltextzugriff (PDF)

Phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration‐resistant prostate cancer

The Prostate, 2019-11, Vol.79 (15), p.1752-1761

2019

Volltextzugriff (PDF)

1 – 25 von 1.073

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Journals Frontfile Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.057)
Mit Volltextzugriff
(1.054)

Publikationsform

Artikel
(1.061)
Berichte
(12)

Sprache

Englisch
(1.073)

Erscheinungsjahr

n.n

Thema

Science & Technology
(971)
Life Sciences & Biomedicine
(930)
Docetaxel
(885)
Humans
(841)
Male
(523)
Oncology
(445)
Chemotherapy
(420)
Middle Aged
(393)
Female
(384)
Aged
(361)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(287)
Prostate Cancer
(258)
Taxoids - Administration & Dosage
(245)
Biological And Medical Sciences
(233)
Medical Sciences
(233)
Treatment Outcome
(223)
Adult
(220)
Tumors
(214)
Metastasis
(176)
Urology & Nephrology
(175)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Tumor‐Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel‐Enhanced Immunotherapy with Polarization toward M1‐Type Macrophages on Triple Negative Breast Cancers

PEG‐PLA nanoparticles decorated with small‐molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells

Bile Acid Tethered Docetaxel‐Based Nanomicelles Mitigate Tumor Progression through Epigenetic Changes

A novel encapsulation approach to enhance the delivery and antitumor activity of docetaxel in breast cancer therapy

Novel co‐delivery of oridonin and docetaxel nanoliposome for an enhanced antitumor effect on esophageal cancer

An improved LC–MS/MS method for determination of docetaxel and its application to population pharmacokinetic study in Chinese cancer patients

Phase II clinical trial of docetaxel and trastuzumab for HER2-positive advanced extramammary Paget's disease (EMPD-HER2DOC)

Role of chemotherapy in prostate cancer

A vitamin D‐based strategy overcomes chemoresistance in prostate cancer

A Population Pharmacokinetic Model of Oral Docetaxel Coadministered With Ritonavir to Support Early Clinical Development

NOTCH3 promotes docetaxel resistance of prostate cancer cells through regulating TUBB3 and MAPK signaling pathway

Secondary analysis of late major gastrointestinal and genitourinary toxicities in unfavorable‐risk prostate cancer patients receiving docetaxel: Insights from a randomized trial

Prospective Observational Study of Ramucirumab Plus Docetaxel After Combined Chemoimmunotherapy in Patients With Non-Small-Cell Lung Cancer

Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer

Radiation recall reaction induced by gemcitabine/docetaxel in children: A retrospective study on risk factors and outcomes

Systemic therapies for metastatic hormone‐sensitive prostate cancer: network meta‐analysis

Intermittent vs continuous docetaxel therapy in patients with metastatic castration‐resistant prostate cancer – a phase III study (PRINCE)

Vitamin E D‐alpha‐tocopheryl polyethylene glycol 1000 succinate‐conjugated liposomal docetaxel reverses multidrug resistance in breast cancer cells

Docetaxel/cabazitaxel and fatty acid binding protein 5 inhibitors produce synergistic inhibition of prostate cancer growth

Neoadjuvant docetaxel plus carboplatin vs epirubicin plus cyclophosphamide followed by docetaxel in triple‐negative, early‐stage breast cancer (NeoCART): Results from a multicenter, randomized controlled, open‐label phase II trial

Reversed‐phase high‐performance liquid chromatography: A fast and efficient analytical method to quantify docetaxel‐loaded pegylated liposomes in release study

Docetaxel reintroduction in patients with metastatic castration‐resistant docetaxel‐sensitive prostate cancer: a retrospective multicentre study

Patient‐reported and clinician‐reported chemotherapy‐induced peripheral neuropathy in patients with early breast cancer: Current clinical practice

Role of 1‐Deoxysphingolipids in docetaxel neurotoxicity

Phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration‐resistant prostate cancer

Aktive Filter

Suchergebnisse filtern